Literature DB >> 33490627

Unusual imaging findings of pancreatobiliary-type intraductal papillary mucinous neoplasm.

Akinobu Koiwai1, Morihisa Hirota1, Atsuko Takasu1, Katsuya Endo1, Takayuki Kogure1, Takayoshi Meguro1, Keigo Murakami2, Kennichi Satoh1.   

Abstract

We experienced a rare case of main duct intraductal papillary mucinous neoplasm (MD-IPMN) without overt mucin production. Histological findings classified the tumor as high-grade dysplasia of pancreatobiliary-type IPMN that has been reported to show high malignant potential with a property to disseminate extensively into pancreatic ducts.
© 2020 The Authors. JGH Open published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  computed tomography; endoscopy; gastroenterology; imaging; magnetic resonance imaging; pancreatic cancer; pancreato‐biliary

Year:  2020        PMID： 33490627      PMCID： PMC7812446          DOI： 10.1002/jgh3.12453

Source DB:  PubMed          Journal:  JGH Open        ISSN： 2397-9070


  6 in total

1.  International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas.

Authors:  Masao Tanaka; Carlos Fernández-del Castillo; Volkan Adsay; Suresh Chari; Massimo Falconi; Jin-Young Jang; Wataru Kimura; Philippe Levy; Martha Bishop Pitman; C Max Schmidt; Michio Shimizu; Christopher L Wolfgang; Koji Yamaguchi; Kenji Yamao
Journal:  Pancreatology       Date:  2012-04-16       Impact factor: 3.996

2.  Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas.

Authors:  Toru Furukawa; Takashi Hatori; Izumi Fujita; Masakazu Yamamoto; Makio Kobayashi; Nobuyuki Ohike; Toshio Morohoshi; Shinichi Egawa; Michiaki Unno; Sonshin Takao; Masahiko Osako; Suguru Yonezawa; Mari Mino-Kenudson; Gregory Y Lauwers; Hiroshi Yamaguchi; Shinichi Ban; Michio Shimizu
Journal:  Gut       Date:  2010-12-30       Impact factor: 23.059

3.  Metachronous intraductal papillary mucinous neoplasms disseminate via the pancreatic duct following resection.

Authors:  Kazumasa Nagai; Yusuke Mizukami; Yuko Omori; Toshifumi Kin; Kei Yane; Kuniyuki Takahashi; Yusuke Ono; Ayumu Sugitani; Hidenori Karasaki; Toshiya Shinohara; Toru Furukawa; Tsuyoshi Hayashi; Toshikatsu Okumura; Hiroyuki Maguchi; Akio Katanuma
Journal:  Mod Pathol       Date:  2019-11-13       Impact factor: 7.842

4.  Pathohistological subtype predicts survival in patients with intraductal papillary mucinous neoplasm (IPMN) of the pancreas.

Authors:  Marius Distler; Stephan Kersting; Marco Niedergethmann; Daniela E Aust; Melanie Franz; Felix Rückert; Florian Ehehalt; Christian Pilarsky; Stefan Post; Hans-Detlev Saeger; Robert Grützmann
Journal:  Ann Surg       Date:  2013-08       Impact factor: 12.969

5.  A resected case of two branch duct-type intraductal papillary mucinous neoplasms showing different clinical courses after a two-year follow-up.

Authors:  Hideki Shibata; Nobuyuki Ohike; Tomoko Norose; Tomohide Isobe; Reika Suzuki; Hideyuki Imai; Akira Shiokawa; Masafumi Takimoto; Akihiro Tabuchi; Yuichi Takano; Eiichi Yamamura; Masatsugu Nagahama; Nobuyuki Takeyama; Kazuaki Yokomizo; Hiroki Mizukami; Jun-Ichi Tanaka; Takeshi Aoki; Masahiko Murakami
Journal:  Clin J Gastroenterol       Date:  2017-03-03

6.  Subtype of intraductal papillary mucinous neoplasm of the pancreas is important to the development of metachronous high-risk lesions after pancreatectomy.

Authors:  Ji Eun Kwon; Kee-Taek Jang; Youngju Ryu; Naru Kim; Sang Hyun Shin; Jin Seok Heo; Dong Wook Choi; In Woong Han
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2019-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.